Fiocruz/NIH Symposium: COVID-19 demands new ways to distribute vaccines

3 May 2022
fiocruz_brazil_large

Persisting Global Health Threats, organized by Fiocruz and by the USA’s National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID-NIH), took place late last month in Rio de Janeiro, Brazil.

It was attended by the likes of Anthony Fauci, the main American epidemiologist and leader of the US task force against the COVID-19 pandemic, and Adrian Hill, director of the Jenner Institute, of the University of Oxford, among many others.

Initially intending to celebrate the long history of cooperation between Fiocruz and NIAID/NIH, the symposium was supposed to have taken place two years ago, but was postponed by the pandemic and acquired a new meaning.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical